Hospira Healthcare Corporation v. Kennedy Institute of Rheumatology
The appeal is dismissed because the prothonotary did not commit a reversible error: she applied established discovery principles (relevance as train of inquiry plus balancing proportionality and burden), acted within her discretion informed by case management knowledge, and reasonably refused or limited numerous discovery requests as irrelevant, duplicative, unduly onerous, seeking expert/legal opinion or resolved by other parties; foreign transcripts are not discoverable other than for impeachment; costs were fixed.
- Citation
- 2015 FC 1292
- Parties
- Plaintiff/moving Party (appellant): Hospira Healthcare Corporation; Defendant/responding Party: The Kennedy Institute of Rheumatology; Plaintiff by Counterclaim/responding Party: The Kennedy Trust for Rheumatology Research; Plaintiff by Counterclaim/responding Party: Janssen Biotech, Inc.; Plaintiff by Counterclaim/responding Party: Janssen Inc.; Plaintiff by Counterclaim/responding Party: CILAG GmbH International; Defendant by Counterclaim/moving Party (appellant): Celltrion Healthcare Co. Ltd.; Defendant by Counterclaim/moving Party (appellant): Celltrion Inc.
- Court
- Federal Court
- Jurisdiction
- Canada
- Judgment Date
- 18 November 2015
- Procedural Posture
- Patent Validity and Infringement (impeachment) With Bifurcated Liability/quantum Proceedings / Appeal From Prothonotary's Order on Discovery Refusals During Examinations for Discovery; Pre Trial Liability Phase
- Outcome
- Appeal dismissed
- Legal Topics
- Validity, Infringement, Scope of Discovery, Standard of Review on Interlocutory Matters, Proportionality, Production of Foreign Deposition Transcripts, Claim Construction, Commercial Success
- Source Language
- English
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Hospira Healthcare Corporation
Plaintiff/moving Party (appellant)
The Kennedy Institute of Rheumatology
Defendant/responding Party
The Kennedy Trust for Rheumatology Research
Plaintiff by Counterclaim/responding Party
Janssen Biotech, Inc.
Plaintiff by Counterclaim/responding Party
Janssen Inc.
Plaintiff by Counterclaim/responding Party
CILAG GmbH International
Plaintiff by Counterclaim/responding Party
Celltrion Healthcare Co. Ltd.
Defendant by Counterclaim/moving Party (appellant)
Celltrion Inc.
Defendant by Counterclaim/moving Party (appellant)
Procedural Posture
Patent Validity and Infringement (impeachment) With Bifurcated Liability/quantum Proceedings / Appeal From Prothonotary's Order on Discovery Refusals During Examinations for Discovery; Pre Trial Liability Phase
Legal Issues
- 1 Applicable standard of review for prothonotary discretionary discovery rulings
- 2 Whether de novo review required for decisions vital to final issue
- 3 Whether prothonotary misapplied relevance/train of inquiry test
Ratio Decidendi
The appeal is dismissed because the prothonotary did not commit a reversible error: she applied established discovery principles (relevance as train of inquiry plus balancing proportionality and burden), acted within her discretion informed by case management knowledge, and reasonably refused or limited numerous discovery requests as irrelevant, duplicative, unduly onerous, seeking expert/legal opinion or resolved by other parties; foreign transcripts are not discoverable other than for impeachment; costs were fixed.
Court Disposition
Appeal dismissed
Orders
- Motion dismissed
- Respondents awarded costs of $6,500 in any event of the cause
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment